Enterprise Value
$3.60 B
-$139.71 M-3.74%
119 min ago
Summary
- As of February 7, 2025, RAPP enterprise value is $3.60 billion, with a fall of -$139.71 million (-3.74%) during the most recent trading day.
- RAPP enterprise value is now -45.07% below its all-time high of $6.55 billion.
Performance
RAPP Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RAPP Enterprise Value Trends
PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
---|---|---|---|
todaytoday | -3.7% | -3.7% | -3.7% |
1 m1 month | -9.4% | -9.3% | -9.3% |
3 m3 months | -40.3% | -40.0% | -40.0% |
6 m6 months | -13.2% | -14.5% | -14.5% |
ytdytd | -9.2% | -9.1% | -9.1% |
1 y1 year | - | - | - |
5 y5 years | - | - | - |
RAPP Enterprise Value Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -12.4% | $2.71 B | +32.7% | |
3 m | 3-month | $6.02 B | -40.3% | $2.71 B | +32.7% |
6 m | 6-month | $6.55 B | -45.1% | $2.71 B | +32.7% |
1 y | 1-year | $6.55 B | -45.1% | $2.71 B | +32.7% |
3 y | 3-year | $6.55 B | -45.1% | $2.71 B | +32.7% |
5 y | 5-year | $6.55 B | -45.1% | $2.71 B | +32.7% |
alltime | all time | $6.55 B | -45.1% | $2.71 B | +32.7% |
Rapport Therapeutics Enterprise Value History
Date | Value |
---|---|
2025 | $3.60 B(-9.2%) |
Date | Value |
---|---|
2024 | $3.96 B |
FAQ
- What is Rapport Therapeutics enterprise value?
- What is the all time high enterprise value for Rapport Therapeutics?
- What is RAPP enterprise value year-to-date change?
What is Rapport Therapeutics enterprise value?
The current enterprise value of RAPP is $3.60 B
What is the all time high enterprise value for Rapport Therapeutics?
Rapport Therapeutics all-time high enterprise value is $6.55 B
What is RAPP enterprise value year-to-date change?
Rapport Therapeutics enterprise value has changed by -$362.79 M (-9.16%) since the beginning of the year